Publication | Closed Access

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial

OncologyHepatologyPhase Ii TrialHepatocellular CarcinomaMedicineLiver PhysiologyPharmacotherapyBiomolecular ExploratoryLiver CancerCancer TreatmentPharmacologyRadiation OncologyTumor MicroenvironmentHealth Sciences